Optos Plc (OPTS.L) Monday released the trading update for the financial year ended 30 September 2012, stating that revenues for the year to 30 September 2012 are expected to exceed $190 million, ahead of market expectations.
The leading medical retinal imaging company stated that Operating profit for the full year is expected to be slightly above market expectations.
Roy Davis, CEO, commented: "I am delighted with the Company's achievements this year and in particular, the manufacturing scale-up and market roll-out of Daytona. The reaction to this instrument has been very positive and I am excited by the opportunities it brings to the business. Our near-term focus is to drive sales of Daytona in all our key markets and to continue our success with the 200Tx instrument in the ophthalmology market."
For comments and feedback: editorial@rttnews.com